Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Harte Hanks (HHS) over the last 16 years, with Q3 2025 value amounting to $6.5 million.

  • Harte Hanks' Cash & Equivalents rose 952.22% to $6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.5 million, marking a year-over-year increase of 952.22%. This contributed to the annual value of $9.9 million for FY2024, which is 4590.5% down from last year.
  • Latest data reveals that Harte Hanks reported Cash & Equivalents of $6.5 million as of Q3 2025, which was up 952.22% from $4.8 million recorded in Q2 2025.
  • Harte Hanks' Cash & Equivalents' 5-year high stood at $26.5 million during Q1 2021, with a 5-year trough of $4.8 million in Q2 2025.
  • In the last 5 years, Harte Hanks' Cash & Equivalents had a median value of $11.0 million in 2024 and averaged $11.8 million.
  • Per our database at Business Quant, Harte Hanks' Cash & Equivalents tumbled by 6731.07% in 2021 and then skyrocketed by 9238.45% in 2023.
  • Quarter analysis of 5 years shows Harte Hanks' Cash & Equivalents stood at $15.1 million in 2021, then crashed by 31.51% to $10.4 million in 2022, then skyrocketed by 77.19% to $18.4 million in 2023, then plummeted by 45.91% to $9.9 million in 2024, then plummeted by 34.47% to $6.5 million in 2025.
  • Its Cash & Equivalents was $6.5 million in Q3 2025, compared to $4.8 million in Q2 2025 and $9.0 million in Q1 2025.